If you have questions about GLP-1 options, diabetes, cholesterol, or a safer weight loss plan, talk with Passion Health Advanced Primary Care
While it found no significant reduction in MACE, it was one of the initial trials that helped expand the safety and tolerability information regarding oral GLP-1 RAs [20]
Acknowledgements The authors are supported by National Institutes of Health (NIH) grants R33HL154252, R01EY035853 and U54CA268083 (P.C.S.), and VA RSF Banks.025 (W.A.B.)
It plays a role in supporting the bodys immune response by helping maintain a balanced and effective immune system
We dont know enough about how to use these drugs in the real world
In one 2024 study, researchers found people with type 2 diabetes taking semaglutide were about four times more likely to develop NAION than people with similar health conditions not on the drug